Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Balance (in shares) at Dec. 31, 2020		17,679,232
Balance at Dec. 31, 2020	$ 56,880	$ 18	$ 117,097	$ (60,235)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for employee purchase plan (in shares)		59,635
Issuance of common stock for employee purchase plan	$ 1,184		1,184
Exercise of stock options (in shares)	71,798	71,798
Exercise of stock options	$ 1,581		1,581
Purchase of capped call	16,134		16,134
Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes (in shares)		184,679
Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes	(2,176)		(2,176)
Stock-based compensation expense	13,172		13,172
Net income (loss)	2,062			2,062
Net change in unrealized gain (loss) on available-for-sale investments	0
Balance (in shares) at Dec. 31, 2021		17,995,344
Balance at Dec. 31, 2021	56,569	$ 18	114,724	(58,173)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for employee purchase plan (in shares)		49,306
Issuance of common stock for employee purchase plan	$ 1,873		1,873
Exercise of stock options (in shares)	39,960	39,960
Exercise of stock options	$ 850		850
Purchase of capped call	57,132		57,132
Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes (in shares)		229,645
Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes	(5,256)		(5,256)
Stock-based compensation expense	14,400		14,400
Issuance of common stock in repayment of convertible notes (in shares)		1,354,348
Issuance of common stock in repayment of convertible notes	55,949	$ 2	55,947
Net income (loss)	(82,340)			(82,340)
Net change in unrealized gain (loss) on available-for-sale investments	$ (94)				(94)
Balance (in shares) at Dec. 31, 2022	19,668,603	19,668,603
Balance at Dec. 31, 2022	$ (15,181)	$ 20	125,406	(140,513)	(94)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for employee purchase plan (in shares)		51,786
Issuance of common stock for employee purchase plan	$ 711		711
Exercise of stock options (in shares)	42,234	42,234
Exercise of stock options	$ 612		612
Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes (in shares)		197,999
Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes	(3,297)		(3,297)
Stock-based compensation expense	8,064		8,064
Net income (loss)	(162,833)			(162,833)
Net change in unrealized gain (loss) on available-for-sale investments	$ 94				94
Balance (in shares) at Dec. 31, 2023	19,960,622	19,960,622
Balance at Dec. 31, 2023	$ (171,830)	$ 20	$ 131,496	$ (303,346)	$ 0